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Abstract
Background: Approximately 10 million Americans enter jails annually. The Centers for Disease Control and Prevention now
recommends routine opt-out HIV testing in these settings. The logistics for performing routine opt-out HIV testing within
jails, however, remain controversial. The objective of this study was to evaluate the optimal time to routinely HIV test newly
incarcerated jail detainees using an opt-out strategy.
Methods: This prospective, controlled trial of routine opt-out HIV testing was conducted among 298 newly incarcerated
male inmates in an urban men’s jail in New Haven, Connecticut. 298 sequential entrants to the men’s jail over a three week
period in March and April 2008 were assigned to be offered routine opt-out HIV testing at one of three points after
incarceration: immediate (same day, n=103), early (next day, n=98), or delayed (7 days, n=97). The primary outcome was
the proportion of men in each group consenting to testing.
Results: Routine opt-out HIV testing was significantly higher for the early (53%: AOR=2.6; 95% CI=1.5 to 4.7) and
immediate (45%: AOR=2.3; 95% CI=1.3 to 4.0) testing groups compared to the delayed (33%) testing group. The
immediate and early testing groups, however, did not significantly differ (p=0.67). In multivariate analyses, factors
significantly associated with routine opt-out HIV testing were assignment to the ‘early’ testing group (p=0.0003) and low
(bond $$5,000, immigration or federal charges or pre-sentencing .30 days) likelihood of early release (p=0.04). Two
subjects received preliminary positive results and one of them was subsequently confirmed HIV seropositive.
Conclusions: In this men’s jail where attrition was high, routine opt-out HIV testing was not only feasible, but resulted in the
highest rates of HIV testing when performed within 24 hours of incarceration.
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Introduction
Approximately 10 million Americans enter jails annually [1].
The Centers for Disease Control and Prevention (CDC) recently
recommended implementing routine opt-out HIV testing in all
healthcare settings, including jails [2]. This presents both a
challenge and an opportunity in correctional settings to expand
access to HIV services to correctional inmates, a population
disproportionately affected by HIV [2,3,4]. The CDC has
identified several issues that must be addressed when developing
model routine opt-out HIV testing strategies in jails [5], including
choosing the timing of testing after entering jail.
We have previously reported in this journal the first prospective,
controlled trial of routine opt-out HIV testing among female
inmates in a jail setting [6]. The objective of this study was to
evaluate the optimal time to offer routine opt-out HIV testing in
an urban jail setting to newly incarcerated male inmates, who
represent close to 90% of all jail detainees in the United States.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Ethics Statement
This study was approved by the Institutional Review Board at
Yale University School of Medicine and by the Connecticut
Department of Correction Research Committee.
Design Overview
The study design, eligibility criteria, subject allocation, study
procedures, definitions, outcome measures and analytic approach
have been previously described for a similar trial in a women’s jail
[6]. For this trial, all 298 consecutive, newly incarcerated male
inmates from March 25, 2008 to April 16, 2008 were offered
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one of three study arms upon admission to the facility: 1)
‘immediate’ (during an initial medical screen the night of
admission); 2) ‘early’ (during a physical exam the following
evening); or 3) ‘delayed’ (7 days after arrival to the facility).
Setting and Participants
This prospective, controlled trial was conducted at the New
Haven Community Correctional Center (NHCCC) in New
Haven, Connecticut, an urban men’s jail that houses primarily
unsentenced detainees as well as those serving sentences #1 year.
The facility’s average daily census is 919 individuals. Similar to
other jails, a brief, standardized medical and psychiatric
assessment is routinely conducted on all inmates, including
medical, sexual, and drug-use histories immediately upon arrival.
Voluntary HIV testing is available by medical referral or by self-
request and often involves being placed on a waiting list. Current
policy in Connecticut requires that in the absence of an emergent
clinical indication, inmates must be beyond the three month
‘‘window period’’ from their last HIV risk behavior to receive an
HIV antibody test. Newly confirmed HIV positive test results are
reported to the Connecticut Department of Public Health as part
of the state’s mandatory reporting system.
Results
The baseline characteristics of the study population appear in
Table 1. The 298 newly incarcerated men were sequentially
assigned to the following testing groups: ‘immediate’ (N=103, the
night of admission), ‘early’ (N=98, the following evening), and
‘delayed’ (N=97, 7 days later). The three study groups did not
differ significantly with respect to any of the social and
demographic characteristics assessed.
The disposition of individuals approached for routine opt-out
HIV testing in this trial is illustrated in Figure 1. Overall, 130
(44%) of 298 inmates assigned to testing groups provided verbal
consent to be swabbed for routine opt-out HIV testing. Among
those assigned to early testing, 52 (53%) accepted HIV testing
versus 46 (45%) in the immediate and 32 (33%) for 7 days post-
entry groups (Figure 2). Compared to the delayed testing group,
the early (OR=2.6; 95% CI=1.5 to 4.7; p=0.001) and
immediate (OR=2.3; 95% CI=1.3 to 4.0; p=0.01) testing
groups were significantly more likely to be swabbed for HIV
testing. The immediate and early testing groups did not differ with
regard to the primary outcome (p=0.67).
There were differences between these two groups, however, in
rates of acceptance among those actually physically available and
medically competent to be approached for testing. Of the 226
subjects that were physically present in the jail at each of the three
time points, acceptability was highest for the early testing group
(N=52/74, 70%), compared to 45% (N=46/103) and 65%
(N=32/49) in the immediate and delayed testing groups,
respectively (see Figure 2).
Stratified by testing group assignment, the reasons that inmates
were not swabbed are depicted in Figure 3. In the immediate
group, 5 (10% of those not swabbed in that group) were medically
incompetent or did not have the capacity to consent, compared
with none in the ‘early’ and in the ‘delayed’ testing groups. In the
‘delayed’ testing group, 48 (75% of those not tested) were no
longer available for testing compared with none in the ‘immediate’
and 24 (57% of those not tested) in the ‘early’ groups. Among the
77 competent subjects who declined testing, 18 (23%) stated they
were not interested in general, 15 (19%) did not perceive
themselves to be at risk, 12 (16%) self-reported they were already
HIV-infected (confirmed by medical record review), and 11 (14%)
stated they were recently tested.
Figure 4 demonstrates the time to release from the facility. The
median duration of incarceration at the facility was 34 days.
Among the 298 subjects approached, 51 (17%) were released
within the first 24 hours following admission, 81 (29%) were no
longer incarcerated after 7 days, 107 (36%) after 14 days, and 142
(48%) were already released at 30 days. Individuals released within
the first 24 hours following admission were less likely to have been
incarcerated previously: 33 (65%) versus 211 (85%) (p=0.0005);
the two groups did not vary on any other characteristics.
Bivariate and multivariate analyses were conducted to deter-
mine predictors associated with being swabbed for routine opt-out
HIV testing (Table 2). In the bivariate analysis, assignment to the
‘immediate’ or ‘early’ testing groups was associated with being
swabbed for HIV testing. In the multivariate analysis, however,
only assignment to the ‘early’ testing group (p=0.0003) and low
likelihood of release (p=0.04) were significantly associated with
being swabbed for HIV testing.
Of the 144 individuals swabbed, 130 (90%) provided written
consent to complete the entire study. Of these, 128 (98.5%) were
HIV-negative and 2 (1.5%) had a preliminary positive test result;
one was a false-positive and the other was confirmed using
Western Blot testing. The one confirmed negative test occurred in
the ‘‘immediate testing group’’. Both individuals who tested
preliminary positive were incarcerated at seven days and both
received their confirmatory test results. Based on the 12 confirmed
individuals known to be HIV-infected and the one newly
diagnosed subject in this study, the minimum HIV prevalence
for this facility is 13/298 (4.4%).
Among the 130 HIV-tested subjects who underwent standard-
ized screening, 15 (12%) exhibited moderate or severe opioid
withdrawal symptoms: 6 (13%) from ‘immediate’, 4 (8%) from
‘early’ group, and 5 (16%) from the ‘delayed’ testing group. Only 3
(2%) individuals were deemed to have increased risk for alcohol
Table 1. Baseline Characteristics of the Study Population
(n=298).
Characteristics Subcategory Value (%)
Age (mean years; SD) 35 (11)
Ethnicity Hispanic 56 (19)
Black 104 (35)
White/Other 138 (46)
High School Graduate Yes 193 (65)
No 105 (35)
Length of Current Incarceration (median
days; IQR)
28 (4–36)
High Likelihood of Early Release* Yes 122 (41)
No 176 (59)
Drug- or Prostitution-Related Offense Yes 46 (15)
No 252 (85)
Previous History of Incarceration Yes 244 (82)
No 54 (18)
Has Medical Insurance Yes 276 (93)
No 22 (7)
*High: any charges directly related to prostitution or drugs.
Low: bond value $$5000, bond sentencing .30 days, immigration or federal
charges, or no bond.
doi:10.1371/journal.pone.0008056.t001
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‘early’, and none from the ‘delayed’ testing group. In addition, 17
(13%) of the 130 tested subjects had evidence of serious mental
illness using the K6 psychological distress scale score: 5 (11%) from
‘immediate’, 9 (17%) from ‘early’, and 3 (9%) from the ‘delayed’
testing group.
Discussion
This study reports the first prospective controlled trial of routine
HIV testing in a men’s jail. Our results have two major public health
implications. First, routine opt-out HIV testing in jails is feasible,
whether provided immediately upon intake or a day or week later. The
operational details of our program should provide guidance to jails
Figure 2. Rapid HIV Testing Swab Results by Assigned Testing
Group.
doi:10.1371/journal.pone.0008056.g002
Figure 3. Reasons Inmates were not Swabbed for HIV Testing.
doi:10.1371/journal.pone.0008056.g003
Figure 1. Disposition of Inmates Approached for HIV Testing.
doi:10.1371/journal.pone.0008056.g001
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available jail population vary over time such that delays in testing result
both in reduced likelihood of testing but also missing the important
opportunity to HIV test those who have never interfaced with the
correctional environment. Second, and perhaps most importantly, the
primaryoutcome from this trial demonstrated that offering routine opt-
out HIV testing to male inmates in this urban jail within the first
24 hours of admission resulted in the highest likelihood of being HIV
tested (53%). This suggests that routine opt-out HIV testing in jails
should be offered as early in the intake process as possible. To balance
the competing factors of risk ofrelease with inmate willingness to accept
testing, it may be beneficial to offer routine opt-out HIV testing at
intake and again at a subsequent medical appointment within 24 hours
if the inmate is not tested the night of intake.
We previously reported in this journal the first prospective,
controlled trial of routine opt-out HIV testing among female
inmates using a similar study design [6]. In that trial, the
proportion of subjects consenting to be swabbed and tested for
HIV was significantly highest 24 hours after admission compared
to testing immediately upon intake (OR=2.3; 95% CI=1.3–4.0;
p=0.005) or 7 days post-entry (OR=2.7; 95% CI=1.5–4.7;
p=0.0007). The proportion of individuals choosing to opt out of
testing the night of admission was high in both the women’s and
men’s studies (32% and 50%, respectively),. Similarly, inmates in
both trials were considerably more willing to accept testing when
offered the day after entry. In this trial, among inmates physically
present in the jail at the time of testing, 55% of those approached
in the immediate group opted out, versus 30% in the early group.
The attrition rate due to inmates quickly bonding out resulted in
the equalization of swabbing rates between these two groups.
In contrast to the women’s jail, however, this trial among male
inmates was conducted at an urban facility with more daily
admissions and a higher rate of release within the first twenty-four
hours. These dynamics of increased attrition in the men’s jail may
account for the lost benefit of waiting until the day following entry
to maximize uptake of HIV testing.
Prior to this study and our trial of routine opt-out HIV testing in a
women’s jail, published works regarding routine opt-out HIV testing
in jail settings have been limited [7,8]. One observational study
c o n d u c t e dr e c e n t l yi naR h o d eI s l a n dj a i ld e m o n s t r a t e dm a r k e d l y
higher rates of acceptability of testing compared to that found in our
study. The likely explanation for this difference is that mandatory
HIV testing of prisoners has been in place in that state for nearly 20
years. As such, nearly all (88%) subjects had previously been tested
within that setting and the authors themselves suggest that HIV
testing was no longer considered as an emotional or ‘‘charged’’ issue.
It can therefore be expected that acceptance of routine opt-out HIV
testing will increase with time as the stigma and unfamiliarity with
testing decreases among correctional staff and inmates. Additionally,
a 4-site, CDC funded study demonstrated that rapid, voluntary HIV
testing is feasible and identified many new people living with HIV.
Figure 4. Time to Release Following Incarceration.
doi:10.1371/journal.pone.0008056.g004
Table 2. Bivariable and Multivariable Predictors of Receipt of Swab.
Uptake Rates, n (%) Bivariable OR (95% CI) Bivariable p-value Multivariable OR (95% CI) Multivariable p-value
Assigned day 0* 55 (53) 2.3 (1.26 to 4) 0.01 2.4 (1.4 to 4.3) 0.00
Assigned day 1* 56 (57) 2.6 (1.5 to 4.7) 0.0013 3.0 (1.7 to 5.6) 0.0003
Assigned day 7* 33 (34) –Referrent– – –Referrent– –
Low Likelihood of Release 52 (43) 0.7 (0.5 to 1.1) 0.10 0.1 (0.1 to 0.7) 0.04
High Likelihood of Release 92 (52) –Referrent– – –Referrent– –
High School Graduate 88 (46) 0.74 (0.5 to 1.2) 0.20 0.8 (0.5 to 1.2) 0.21
Not High School Graduate 56 (53) –Referrent– – –Referrent– –
Has Medical Insurance 131 (47) 1.6 (0.7 to 3.9) 0.30 2 (0.8 to 5.1) 0.15
No Medical Insurance 13 (59) –Referrent– – –Referrent– –
Age (years) at Entry** – 0.9 (0.72 to 1.12) 0.32 -Out of Model- –
Low HIV-Risk Offense 18 (39) –Referrent– – -Out of Model- –
High HIV-Risk Offense 126 (50) 0.7 (0.4 to 1.3) 0.18 -Out of Model- –
White/Other 49 (47) –Referrent– – -Out of Model- –
Black 29 (52) 1 (0.6 to 1.5) 0.73 -Out of Model- –
Hispanic 66 (48) 1.2 (0.7 to 2.2) 0.58 -Out of Model- –
No Previous Incarceration 23 (43) –Referrent– – -Out of Model- –
Previous Incarceration 121 (50) 1.4 (0.8 to 2.5) 0.35 -Out of Model- –
*OR Comparing day 1 or day 7, respectively to day 0.
**The calculated OR represents the added likelihood conferred by every 10 years of age.
doi:10.1371/journal.pone.0008056.t002
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thereby potentially missing a large number of high risk individuals
whowerereleasedpriortotesting[9].NewinitiativesexaminingHIV
testing strategies in jails are now underway [10].
In addition, a key factor contributing to the higher rate of routine
opt-out HIV testing within the first 24 hours of admission was that
the testing procedures were linked to a routine clinical activity
(intake or physical exam) with clinical personnel. This policy, of
linking routine opt-out HIV testing with routine clinical activities,
makes logistical sense and should be considered when implementing
testing in the future. It also helps to demonstrate to inmates that
HIV testing is simply a component of comprehensive primary
healthcare. Future observational and controlled studies should
assess which staff members should perform testing and delivery of
both positive and negative HIV test results during the chaotic post-
entry period. Our study did not assess this fully; we utilized jail staff
for intake, testing, and follow-up of positive HIV test results, while
all our own research staff provided negative results.
As is typical of many urban jails in the United States, this facility
houses a population with rapid turnover. Nearly a fifth of new
admissions were released by the next day, with 29% no longer
remaining in the facility within a week. This raises significant
questions about the current policy in Connecticut of requiring HIV
testing only on those inmates with at least 90 days since their last
HIV risk behavior. Continuing such a policy would result in nearly
three quarters of jail detainees being ineligible for HIV testing
because they would already be released. Delivery of test results,
particularly for individuals who have blood drawn for confirmatory
testing, will prove difficult among this transient population. In this
study, only one individual was released prior to receiving his
confirmatory negative test result, and both individuals who tested
preliminarily positive were incarcerated at 7 days to receive their
final test results. If routine opt-out HIV testing is to be broadly
implemented in our nation’s jails, however, delivery of test results
will remain an important issue and requires further resolution.
Logistical issues of providing results in the jail will be incumbent on
correctional authorities to resolve, yet public health infrastructure
must be maintained to address case finding and delivery of results to
those who leave before HIV testing results are available.
An additional important finding was that those having a low
likelihood for release were more likely to consent to testing,
regardless of group assignment. This suggests that, in jail systems
with high volumes that preclude testing of all inmates at entry,
triage systems could be useful in focusing initial testing efforts on
those inmates for whom early release is more likely. While this
study did diagnose one new individual with HIV, it likely missed
many other high risk individuals who left the facility before being
offered testing as part of their assigned testing group.
There are several important limitations of the present study.
Owing to logistical difficulties, we could not undertake a true
randomized trial. This makes it possible that confounders, such as
cohort effects from particular peer leaders’ influence on testing
uptake, biased our results (internal validity). Our large sample size
and final effect size suggests, however, that the differences detected
here were real. Additionally, since our trial was conducted at only
one men’s jail, its external validity will itself have to be assessed by
studies from other sites.
In conclusion, our study confirms that routine opt-out HIV testing
in a jail setting is feasible and that early testing will likely result in the
largest number of individuals being tested. Early testing also results in
testing a larger proportion of those who have never been within the
correctional system before and have previously received an HIV test.
Such programs, if implemented properly, will result in identifying
individuals with HIV who do not know they are infected and increase
their likelihood of reducing their HIV risk behaviors and increasing
their access to HIV treatment and prevention services.
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